Guillain-Barre syndrome is a rare but serious condition which needs urgent treatment in hospital to prevent it progressing.

The UK’s drugs regulator has advised healthcare professionals to alert RSV vaccine recipients to Guillain-Barré syndrome symptoms, although the risk remains low.

The medicines regulator has issued a warning to NHS health staff about a small increased risk of a rare condition affecting the nerves in people vaccinated against respiratory syncytial virus (RSV).

The UK drug watchdog has issued an alert to the NHS after the RSV jab was linked to a rare condition that needs "urgent treatment" ...